Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.

Christian Dejaco Alessia Alunno Johannes W J Bijlsma Annelies Boonen Bernard G Combe Axel Finckh Pedro M MachadoIvan PadjenFrancisca Sivera Tanja Alexandra Stamm Frank Buttgereit

Published in: Annals of the rheumatic diseases (2020)

Measures related to containment of COVID-19 pandemic led to a perceived delay between symptom onset and a first rheumatological visit, postponement of treatment decisions, and shortage of HCQ and TCZ, thereby negatively impacting early treatment and treat-to-target strategies.

Keyphrases

oxidative stress
physical activity
depressive symptoms
social support
combination therapy
smoking cessation